Evidence map›Paper›PMID 22004246›Full record

ReviewACS chemical biology2012

The curious chemical biology of cytosine: deamination, methylation, and oxidation as modulators of genomic potential.

Christopher S Nabel, Sara A Manning, Rahul M Kohli

Abstract readReview
In one paragraph

Review in ACS chemical biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. High UV damage and low repair, but not cytosine deamination, stimulate mutation hotspots at ETS binding sites in melanoma.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  7. Review
  8. Article
  9. Revealing Drivers for Carboxy-ACS chemical biology · 2023
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Christopher S NabelDepartment of Medicine, Raymond and Ruth Perelman School of Medicine, University of Pennsylvania, Philadelphia, 19104, United States.
Sara A Manning
Rahul M Kohli

Funding

Elucidating the Chemistry and Biology of Nucleic Acid Cytidine Deaminases in HIVK08AI089242 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI KOHLI, RAHUL MANU · 2010 to 2014
$660k
NIAID NIH HHS K08 AI089242NIAID NIH HHS K08-AI089242
6 · The paper itself

Abstract

A multitude of functions have evolved around cytosine within DNA, endowing the base with physiological significance beyond simple information storage. This versatility arises from enzymes that chemically modify cytosine to expand the potential of the genome. Some modifications alter coding sequences, such as deamination of cytosine by AID/APOBEC enzymes to generate immunologic or virologic diversity. Other modifications are critical to epigenetic control, altering gene expression or cellular identity. Of these, cytosine methylation is well understood, in contrast to recently discovered modifications, such as oxidation by TET enzymes to 5-hydroxymethylcytosine. Further complexity results from cytosine demethylation, an enigmatic process that impacts cellular pluripotency. Recent insights help us to propose an integrated DNA demethylation model, accounting for contributions from cytosine oxidation, deamination, and base excision repair. Taken together, this rich medley of alterations renders cytosine a genomic "wild card", whose context-dependent functions make the base far more than a static letter in the code of life.

Indexed as

Gene Expression RegulationGenomeGenomics5-MethylcytosineAdaptation, PhysiologicalAnimalsCytosineDeaminationDNADNA RepairHumansMethylationMiceMice, KnockoutOxidation-ReductionPolymorphism, Genetic5-hydroxymethylcytosine5-MethylcytosineCytosineDNA

Identifiers

PMID22004246
PMCPMC3262930

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.